Biophan, FDA Move Forward On MRI-Device Safety Guidelines
This article was originally published in The Gray Sheet
Executive Summary
FDA and Biophan Technologies say they have identified key factors that need to be considered in assessing the safety of pacemakers, defibrillators and neurostimulators in patients who undergo magnetic resonance imaging
You may also be interested in...
MRI Safety Guidance Outlines Testing, Labeling Terms For Passive Implants
An Aug. 21 FDA guidance document on device safety for magnetic resonance imaging offers makers of passive implants three options for describing their products in labeling - MR safe, MR unsafe or MR conditional
MRI Safety Guidance Outlines Testing, Labeling Terms For Passive Implants
An Aug. 21 FDA guidance document on device safety for magnetic resonance imaging offers makers of passive implants three options for describing their products in labeling - MR safe, MR unsafe or MR conditional
Biophan, FDA To Research MRI-Device Compatibility
A research partnership between Biophan Technologies and FDA aims to make it safer for patients with implanted medical devices to undergo magnetic resonance imaging (MRI) procedures